Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.4 CAD 0.01 ( 1.27%)
Last update at 2026-11-04T15:51:00Z
VOLUME
5000
Market Cap
111.71M

Momentum Score

…

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flowers, pre-rolls, concentrates, vapes, edibles, tablets, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Effin', Miss Grass, Lowell Smokes, Flower by Edie Parker, 1906, AiroPro, and Binske brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in Morristown, New Jersey.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.40
Low
0.40
High
52 Week Price Range
0.24
Low
1.20
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Ascend Wellness Holdings is a U.S. multi-state cannabis operator that cultivates, manufactures and retails cannabis products in several states. Long-term growth drivers include expansion into adult-use markets, a diversified state footprint and vertical integration across cultivation, branded products and wholesale distribution that could support revenue growth and operating efficiency.
Principal risks include federal and state regulatory uncertainty, licensing and compliance exposure, intense competition and execution or capital constraints that could pressure margins.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.40
Dividend Yield
-
Revenue TTM
516.04M
Revenue Per Share
2.50
Gross Profit TTM
171.42M
Debt / Equity
-
ROE
-188.62%
Net Debt
220.17M
ROCE
0.63%
Diluted EPS TTM
-0.42

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -39.82M -14.76M -39.21M -80.94M -5.14M
Minority interest - - 0.00M 0.00M -1.60M
Net income -84.99M -48.21M -80.90M -122.66M -25.44M
Selling general administrative 144.48M 129.43M 122.65M 100.00M 44.87M
Gross profit 184.21M 155.12M 134.56M 135.97M 60.91M
Reconciled depreciation 68.12M 60.04M 38.24M 23.58M 13.43M
Operating income 4.75M -3.85M -2.18M 19.91M 8.13M
Interest expense 39.79M 36.98M 30.26M 57.35M 12.99M
Tax provision 45.17M 33.45M 41.69M 41.72M 18.70M
Net interest income -39.79M -36.98M -30.26M -57.35M -12.99M
Total revenue 561.60M 518.59M 405.93M 332.38M 143.73M
Total operating expenses 556.85M 522.43M 408.11M 312.47M 135.60M
Cost of revenue 377.39M 363.47M 271.36M 196.41M 82.82M
Total other income expense net -4.78M 26.07M -6.77M -43.50M -0.28M
Net income from continuing ops -84.99M -48.21M -80.90M -122.66M -23.84M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 900.43M 919.55M 872.16M 723.44M 427.75M
Intangible assets 205.50M 221.45M 221.09M 59.27M 50.46M
Other current assets 0.35M 2.50M 0.74M 8.88M 25.55M
Total liab 828.63M 776.68M 708.75M 546.96M 423.96M
Total stockholder equity 70.98M 142.87M 163.41M 176.48M 3.79M
Other current liab 5.06M 6.77M 21.66M 5.15M 4.33M
Capital stock 0.20M 0.21M 0.19M 0.17M 0.00M
Retained earnings -400.36M -315.36M -267.15M -186.25M -63.59M
Good will 49.60M 47.54M 44.37M 42.97M 22.80M
Cash 88.25M 72.51M 74.15M 155.48M 56.55M
Total current liabilities 144.54M 92.69M 110.95M 117.39M 115.28M
Net debt 220.17M 236.21M 256.48M 103.31M 155.06M
Short long term debt 73.88M 11.15M 11.33M 27.94M 59.33M
Total current assets 229.38M 228.86M 198.74M 258.01M 134.18M
Net receivables 36.54M 28.30M 14.10M 7.61M 6.23M
Long term debt 234.54M 297.56M 319.30M 230.85M 152.28M
Inventory 89.55M 95.29M 97.53M 65.59M 29.00M
Accounts payable 26.41M 34.69M 17.07M 5.54M 7.36M
Non currrent assets other 16.43M 23.06M 19.28M 19.57M 12.73M
Non current assets total 671.05M 690.69M 673.42M 465.42M 293.57M
Capital lease obligations 272.69M 264.75M 232.45M 199.96M 158.53M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -37.20M -59.89M -114.25M -113.23M -30.87M
Net borrowings 0.73M -23.56M 81.50M 180.23M -
Total cash from financing activities -20.35M -17.08M 71.28M 252.35M 82.17M
Net income -84.99M -48.21M -80.90M -122.66M -25.44M
Change in cash 15.75M -1.64M -81.33M 97.38M 45.29M
Begin period cash flow 72.51M 74.15M 155.48M 58.10M 12.80M
End period cash flow 88.25M 72.51M 74.15M 155.48M 58.10M
Total cash from operating activities 73.29M 75.33M -38.36M -41.74M -6.00M
Issuance of capital stock 0.00M 7.00M 0.00M 86.06M 0.00M
Depreciation 68.12M 60.04M 38.24M 23.58M 13.43M
Change to inventory 1.81M -14.88M -43.81M -41.41M -11.89M
Change to account receivables -8.24M -14.20M -6.48M -1.34M -6.01M
Sale purchase of stock -2.75M 0.00M 0.00M - -
Capital expenditures 35.23M 40.19M 125.89M 88.43M 26.55M
Change in working capital 63.32M 26.18M -31.14M -37.76M -0.74M
Stock based compensation 18.61M 19.78M 18.98M 23.09M 0.68M
Other non cash items 20.52M 30.04M 21.87M 75.04M 5.46M
Free cash flow 38.06M 35.14M -164.25M -130.17M -32.55M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AAWH-U
Ascend Wellness Holdings Inc.
0.01
1.27%
0.40 - 10.88 0.22 59.95 1.23 7.98
GTII
Green Thumb Industries Inc
-0.29
3.06%
9.20 14.70 34.84 1.91 0.86 1.61 3.95
CL
Cresco Labs Inc
-0.05
5.68%
0.83 - 105.26 0.70 0.99 1.32 42.44
JUSH
Jushi Holdings Inc
-0.03
4.17%
0.69 - 17.86 0.52 0.69 1.41 9.56
GRIN
Grown Rogue International Inc
0.01
1.96%
0.52 23.50 - 3.62 4.10 3.13 11.19

Profile*

Ascend Wellness Holdings Inc.

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flowers, pre-rolls, concentrates, vapes, edibles, tablets, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Effin', Miss Grass, Lowell Smokes, Flower by Edie Parker, 1906, AiroPro, and Binske brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in Morristown, New Jersey.

44 Whippany Road, Morristown, NJ, United States, 07960

646 661 7600

2400

Name Title Year Born
Mr. Abner B. Kurtin Co- Founder & Executive Chairman of the Board 1967
Mr. Samuel Brill CEO & Director 1974
Mr. Francis Perullo Co-Founder, President & Director 1977
Mr. Roman Nemchenko Chief Financial Officer NA
Mr. Michael McLaughlin Chief Operations Officer NA
Mr. David Gacom Chief Commercial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…